Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury

Zarbock, Alexander; Küllmar, Mira; Kindgen‐Milles, Detlef; Wempe, Carola; Gerß, Joachim; Brandenburger, Timo; Dimski, Thomas; Tyczynski, Bartosz; Jahn, Michael; Mülling, Nils; Mehrländer, Martin; Rosenberger, Peter; Marx, Gernot; Philipp Simon, Tim; Jaschinski, Ulrich; Deetjen, Philipp; Putensen, Christian; Schewe, Jens‐Christian; Kluge, Stefan; Jarczak, Dominik; Slowinski, Torsten; Bodenstein, Marc; Meybohm, Patrick; Wirtz, Stefan; Moerer, Onnen; Kortgen, Andreas; Simon, Philipp; M. Bagshaw, Sean; A. Kellum, John; Meersch, Melanie; Investigators and the Sepnet Trial Group, RICH

doi:10.1001/jama.2020.18618

Public

Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury

Published in JAMA • Oct 23, 2020

Authors:

Alexander Zarbock

Mira Küllmar

Detlef Kindgen‐Milles

Abstract

Importance: Although current guidelines suggest the use of regional citrate anticoagulation (which involves the addition of a citrate solution to the blood before the filter of the extracorporeal dialysis circuit) as first-line treatment for continuous kidney replacement therapy in critically ill pa...

Subject

Medicine

Renal replacement therapy

Acute kidney injury

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!